Ensayos clínicos patrocinados por Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network
Total 11 resultados
-
Ottawa Hospital Research InstituteCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...TerminadoObesidad | Cáncer | Tromboembolismo venosoCanadá
-
Dr. Kerstin de WitCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...ReclutamientoTrombosis venosa profunda (TVP)Canadá
-
Dr. Kerstin de WitCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...Terminado
-
University of CalgaryCanadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...TerminadoAspirina | Tromboembolismo venoso | Periodo PospartoCanadá, Francia, Irlanda, Países Bajos
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...Reclutamiento
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...ReclutamientoFibrilación auricularCanadá
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...TerminadoTromboembolismo venosoCanadá
-
Sudeep ShivakumarCanadian Institutes of Health Research (CIHR); Nova Scotia Health Authority; Canadian...ReclutamientoTromboembolismo venosoCanadá
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism... y otros colaboradoresAún no reclutandoTromboembolismo venoso | Cáncer urológico
-
University of ManitobaCanadian Institutes of Health Research (CIHR); Ozmosis Research Inc.; Canadian... y otros colaboradoresReclutamientoLa comunidad adquirió neumoníaCanadá, Estados Unidos, Brasil
-
Ottawa Hospital Research InstituteCanadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)... y otros colaboradoresActivo, no reclutandoMielofibrosis primaria | Tromboembolismo venoso (TEV) | Policitemia Vera (PV) | Trombocitemia Esencial (TE) | Mutación JAK2 | Neoplasia mieloproliferativa (NMP)Canadá